Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Reading Rheum

David G. Borenstein, MD  |  

Handpicked Reviews of Contemporary Literature

Ortho Angle

Alison P. Toth, MD  |  

Where rheumatology and orthopedics meet

Value-Based Purchasing: The Future of US HealthCare?

  |  

Purchasers of healthcare are beginning to take a more active role in ensuring they receive value for their health care dollars, and these savvy shoppers want to develop programs to increase the quality and efficiency of the care they purchase. This movement has given rise to the concept of value-driven healthcare, commonly called value-based purchasing. Over the next three months, “From the College” will take a look at this type of purchasing and provide rheumatologists and rheumatology health professionals with practical advice on how to stand out to these value-based purchasers.

Make a Difference by the End of Summer: Contact Congress

  |  

The more personal your contact with your elected officials, the more effective it will be. Although a personal discussion with a member of Congress is positive, a meeting or telephone conversation with one of his or her staff is just as valuable.

ARHP Angle: We Need a Few Good Leaders!

Pamela Degotardi, PhD  |  

Flying back from Cincinnati, where I’d been attending a meeting of the ARHP Committee on Nominations, it occurred to me that some members might be intrigued by the process of how ARHP officers and committee and subcommittee chairs are selected. While I do realize that some members aren’t interested in the structural organization of ARHP, I know some may ask, “Why was she selected and not me?”

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

  |  

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.